In addition, a similar effect was observed in NCX1 knocking-down combined with BTZ treatment (Fig. 2b), indicating that inhibition of NCX1 synergized with BTZ to suppress MM cell viability. Here, SLC8A1 is linked to Miyoshi myopathy.